The risk stratification of prostate cancer includes serum PSA level, clinical stage and Gleason score; a Gleason score of >8 is considered an independent predictor of high‐risk disease with increased rates of treatment failures and poorer outcomes. This evidence concerns the gene KLK3 and prostate cancer.